Lynparza Combination Shows Promise in Treatment of Small Cell Lung Cancer

06:34 EDT 17 Aug 2019 | Cancer Connect

Early phase trial suggests PARP inhibitor combination show promise in treating hard to treat patients with SCLC

More From BioPortfolio on "Lynparza Combination Shows Promise in Treatment of Small Cell Lung Cancer"